Efficacy and Safety Study of Teneligliptin (MP-513) in Combination With Insulin in Patients With Type 2 Diabetes
Status:
Completed
Trial end date:
2016-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of Teneligliptin in
combination with Insulin in patients with type 2 Diabetes for 16 weeks administration and to
evaluate the safety and efficacy of Teneligliptin in combination with Insulin with an
extension treatment for up to 52 weeks.